Knut E.

Knut E. is an accomplished professional in the field of medicinal chemistry and oncology research, currently serving as Vice President and Oncology Research Portfolio Lead at Bayer since 2008. Previously held multiple leadership roles at Bayer, including Vice President of Therapeutic Modalities and Vice President of Medicinal Chemistry, managing early research areas focused on oncogenic signaling. Knut E. has also worked in various scientific roles at Schering Aktiengesellschaft, Zentaris AG, ASTA Medica, and completed a PostDoc at Goethe University Frankfurt/Main. Educational qualifications include a PostDoc in Medicinal and Pharmaceutical Chemistry from Imperial College London and a Dipl. Chemiker and Dr. rer. nat. in Organic Chemistry from Technische Universität Berlin.